Company Overview of Romark, L.C.
Romark, L.C., a pharmaceutical company, is engaged in the discovery, development, and commercialization of innovative small molecules for treating infectious diseases and cancers. The company provides thiazolide and nitazoxanide antiviral drugs for the treatment of diarrhea, acute uncomplicated influenza, and chronic hepatitis C. It serves customers worldwide. The company was founded in 1994 and is based in Tampa, Florida. It has manufacturing facilities in Landen, Belgium; and Manatí, Puerto Rico.
3000 Bayport Drive
Tampa, FL 33607
Founded in 1994
Key Executives for Romark, L.C.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Romark, L.C., please visit www.romark.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.